CURV Q2 net sales and adjusted EBITDA met guidance; full-year outlook raised
CURV reported Q2 2026 net sales of $231.7M and adjusted EBITDA of $23.3M, both within guidance. Comparable sales fell 6.3% year over year, while July showed a positive inflection. Full-year outlook was raised.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.